Delivery Order SPE2DB20D3101-SPE2DB25FQZS8
Award Date
1/23/25
Potential Completion Date
1/24/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NovologTM 100 Unit/mL FlexPen® 3mL, a prescription insulin medication, to the Defense Logistics Agency (DLA). The $1,838.16 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 6, 2023. The contract has an ultimate completion date of April 7, 2023 and is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of NovologTM 100 unit/mL FlexPen 3mL to the Defense Logistics Agency (DLA). The $1,329.99 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 25, 2022, with a completion date of March 28, 2022. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of NovologTM 100 Unit/mL FlexPen 3mL medical devices to the Defense Logistics Agency (DLA). The $2,831.62 firm-fixed-price delivery order was issued to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 22, 2024 and was awarded on November 21, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of NovologTM 100 unit/mL FlexPen 3mL, a prescription medication used to treat diabetes. The $1,911.12 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price and runs through November 1, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award is for the delivery of NovologTM 100 Unit/mL FlexPen 3mL, a prescription medication, to the Defense Logistics Agency (DLA). The $4,035.14 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 1, 2024 and is not designated as a set-aside requirement. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds significant...
This federal contract award is for the delivery of NovologTM 100 unit/mL FlexPen 3mL, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The fixed-price delivery order, valued at $5,665.73, has an ultimate completion date of December 5, 2023. It was awarded on December 4, 2023, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of NovologÒ 100 Unit/mL FlexPenÒ 3mL medical supplies. The $1,274.60 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 6, 2023. The contract is not designated with any set-aside requirements. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Novolog 100 Unit/mL FlexPen 3mL, a type of insulin medication, to the Defense Logistics Agency (DLA). The $1,361.60 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 24, 2022, with a performance completion date of June 27, 2022. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,073.54 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 12, 2024, with a completion date of December 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is for the delivery of Novolog 100 unit/mL Flexpen 3mL to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,084.80 and is a firm fixed-price delivery order that runs through March 23, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a...